Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Tianjin Hezhi Guangping Pharmaceutical Co., Ltd. is a comprehensive pharmaceutical enterprise located in the Wuqing Development Zone of Tianjin, China. Established in 2016, the company integrates research and development, production, and sales of both chemical drugs and traditional Chinese medicines (TCM). Its manufacturing facility is GMP-certified and equipped to produce various dosage forms, including tablets, capsules, and granules. The company's product portfolio primarily targets respiratory health, cardiovascular conditions, and gastrointestinal disorders. Hezhi Guangping is closely associated with the Hezhi Youde (Fohow) Group, serving as a key manufacturing hub for the group's health-related pharmaceutical products. The company emphasizes the modernization of traditional therapies alongside the production of high-quality generic chemical medications.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on 天津和治广平药业.